BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
1301 – 1310 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
(
- Contribution to journal › Article
-
Mark
PBX3 is a putative biomarker of aggressive prostate cancer
(
- Contribution to journal › Article
-
Mark
Incidence and familial risk of pleural mesothelioma in Sweden : A national cohort study
(
- Contribution to journal › Article
-
Mark
High resolution digital autoradiographic and dosimetric analysis of heterogeneous radioactivity distribution in xenografted prostate tumors
(
- Contribution to journal › Article
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
-
Mark
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Association of family history of type 2 diabetes with prostate cancer : A national cohort study
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article
-
Mark
Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study
(
- Contribution to journal › Article